Catheterization and Cardiovascular Interventions

Volume 72, Issue 5 pp. 636-640

Coronary Artery Disease

Percutaneous saphenous vein graft intervention with sequential embolic protection devices: Complementing lesion anatomy with embolic protection device

Parker Grow MD,

Parker Grow MD

Emory University School of Medicine, Emory University Hospital, Atlanta, Georgia

Search for more papers by this author

S. Tanveer Rab MD, FACC, FSCAI,

Corresponding Author

S. Tanveer Rab MD, FACC, FSCAI

[email protected]

Emory University School of Medicine, Emory University Hospital, Atlanta, Georgia

Interventional Cardiologist, Emory University School of Medicine, Cardiac Catheterization Lab, Emory University Hospital, Room C-430, 1364 Clifton Road, NE, Atlanta, GA 30322Search for more papers by this author

Parker Grow MD,

Parker Grow MD

Emory University School of Medicine, Emory University Hospital, Atlanta, Georgia

Search for more papers by this author

S. Tanveer Rab MD, FACC, FSCAI,

Corresponding Author

S. Tanveer Rab MD, FACC, FSCAI

[email protected]

Emory University School of Medicine, Emory University Hospital, Atlanta, Georgia

First published: 22 May 2008

https://doi.org/10.1002/ccd.21644

Citations: 3

Share a link

Email
Wechat
Bluesky

Abstract

Saphenous vein graft (SVG) percutaneous coronary intervention (PCI) carries unique technical challenges requiring the utilization of embolic protection devices (EPDs) to reduce the adverse events associated with distal embolization. Distal embolization is a common and almost ubiquitous consequence of SVG PCI due to the soft and friable nature of the SVG lesions. We describe a case of revascularizing a SVG with tandem stenoses employing the use of two different EPDs that complemented their respective lesion's location within the SVG. © 2008 Wiley-Liss, Inc.

REFERENCES

1 Baim DS,Wahr D,George B,Leon MB,Greenberg J,Cutlip DE,Kaya U,Popma JJ,Ho KK,Kuntz RE. Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002; 105: 1285–1290.
10.1161/01.CIR.0000012783.63093.0C
PubMed Web of Science® Google Scholar
2 Stone GW,Rogers C,Hermiller J,Feldman R,Hall P,Haber R,Masud A,Cambier P,Caputo RP,Turco M,Kovach R,Brodie B,Herrmann HC,Kuntz RE,Popma JJ,Ramee S,Cox DA. FilterWire EX Randomized Evaluation Investigators. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation 2003; 108: 548–553.
10.1161/01.CIR.0000080894.51311.0A
PubMed Web of Science® Google Scholar
3 Smith SCJr,Feldman TE,Hirshfeld JWJr,Jacobs AK,Kern MJ,King SBIII,Morrison DA,O'Neil WW,Schaff HV,Whitlow PL,Williams DO,Antman EM,Adams CD,Anderson JL,Faxon DP,Fuster V,Halperin JL,Hiratzka LF,Hunt SA,Nishimura R,Ornato JP,Page RL,Riegel B. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006; 113: e166–e286.
PubMed Web of Science® Google Scholar
4 Hiscock M,Oqueli E,Dick R. Percutaneous saphenous vein graft intervention—A review. Heart, Lung Circ 2007; 16: S51–S55.
10.1016/j.hlc.2007.03.016
Google Scholar
5 Hong MK,Mehran R,Dangas G,Mintz GS,Lansky AJ,Pichard AD,Kent KM,Satler LF,Stone GW,Leon MB. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 1999; 100: 2400–2405.
10.1161/01.CIR.100.24.2400
CAS PubMed Web of Science® Google Scholar
6 Keeley EC,Velez CA,O'Neill WW,Safian RD. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol 2001; 38: 659–665.
10.1016/S0735-1097(01)01420-6
CAS PubMed Web of Science® Google Scholar
7 de Feyter PJ. Percutaneous treatment of saphenous vein bypass graft obstructions: A continuing obstinate problem. Circulation 2003; 107: 2284–2286.
10.1161/01.CIR.0000069360.38675.22
CAS PubMed Web of Science® Google Scholar
8 Cox D,Masud A,Myers F,Kovach R,Cambier P,Brodie BR,Mishkel G,Hermiller J,Tully G,Stone G. Stenting in saphenous vein grafts with distal protection using the second generation FilterWire EZ: The BLAZE registry (abstr). Am J Cardiol 2003; 92( Suppl 6): 33L.
PubMed Web of Science® Google Scholar
9 Cragun D,Heuser R. Embolic protection devices in saphenous vein graft interventions. J Interv Cardiol 2006; 19: 525–529.
10.1111/j.1540-8183.2006.00204.x
PubMed Google Scholar
10 Mauri L,Cox D,Hermiller J,Massaro J,Wahr J,Tay SW,Jonas M,Popma JJ,Pavliska J,Wahr D,Rogers C. The PROXIMAL trial: Proximal protection during saphenous vein graft intervention using the proxis embolic protection system. J Am Coll Cardiol 2007; 50: 1442–1449.
10.1016/j.jacc.2007.06.039
PubMed Web of Science® Google Scholar

Citing Literature

Volume72, Issue5

1 November 2008

Pages 636-640

SCAI Member Sign in

Percutaneous saphenous vein graft intervention with sequential embolic protection devices: Complementing lesion anatomy with embolic protection device

Abstract

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Percutaneous saphenous vein graft intervention with sequential embolic protection devices: Complementing lesion anatomy with embolic protection device

Abstract

REFERENCES

Citing Literature

References

Related

Information